Shares of Consort Medical plc (LON:CSRT) have been assigned an average rating of “Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is GBX 1,200.80 ($16.28).

A number of analysts recently issued reports on CSRT shares. Stifel Nicolaus reissued a “buy” rating and set a GBX 1,250 ($16.95) price objective on shares of Consort Medical in a report on Thursday, November 9th. N+1 Singer cut Consort Medical to a “hold” rating in a report on Tuesday, December 5th. Shore Capital reaffirmed a “buy” rating on shares of Consort Medical in a report on Tuesday, December 5th. Finally, Numis Securities raised their price target on Consort Medical from GBX 1,084 ($14.70) to GBX 1,144 ($15.51) and gave the company a “hold” rating in a report on Wednesday, December 6th.

Shares of Consort Medical (CSRT) opened at GBX 1,150 ($15.60) on Tuesday. The stock has a market capitalization of $569.71 and a PE ratio of 2,875.00. Consort Medical has a 1-year low of GBX 965 ($13.09) and a 1-year high of GBX 1,224 ($16.60).

The firm also recently declared a dividend, which will be paid on Friday, February 16th. Shareholders of record on Thursday, January 18th will be issued a GBX 7.44 ($0.10) dividend. The ex-dividend date of this dividend is Thursday, January 18th. This represents a dividend yield of 0.66%.

COPYRIGHT VIOLATION WARNING: “Consort Medical plc (CSRT) Receives Average Recommendation of “Buy” from Analysts” was reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at

Consort Medical Company Profile

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Analyst Recommendations for Consort Medical (LON:CSRT)

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with's FREE daily email newsletter.